0.09Open0.09Pre Close0 Volume59 Open Interest7.50Strike Price0.00Turnover172.36%IV89.75%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.09Extrinsic Value100Contract SizeAmericanOptions Type0.1214Delta0.1122Gamma44.44Leverage Ratio-0.0073Theta0.0003Rho5.40Eff Leverage0.0021Vega
Alto Neuroscience Stock Discussion
Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology
Wednesday, 11th December at 8:03 am
– Data generated from Alto's precision psychiatry platform and clinical-stage product candidates highlighted across three poster presentations and a panel discussion –
– New preclinical data from a reverse translation study demonstrates the link between the mechanism of ALTO-300 and the EEG biomarker used for...
<- Blackrock ->
$Alto Neuroscience (ANRO.US)$
sec.gov/Archive...
#myANROanalysis
Larger Image: tradingview.com...
$Alto Neuroscience (ANRO.US)$
No comment yet